Improved Treatment Satisfaction With a New Human Subcutaneous Immunoglobulin (SCIG 20%) in Patients Previously Treated With IVIG
Journal of Allergy and Clinical Immunology - United States
doi 10.1016/j.jaci.2016.12.707
Full Text
Open PDFAbstract
Available in full text
Date
February 1, 2017
Authors
Publisher
Elsevier BV